CLBCX
Price
$40.72
Change
-$0.01 (-0.02%)
Updated
Jul 2 closing price
Net Assets
287.61B
FKIQX
Price
$2.55
Change
+$0.02 (+0.79%)
Updated
Jul 2 closing price
Net Assets
79.72B
Interact to see
Advertisement

CLBCX vs FKIQX

CLBCX vs FKIQX Comparison Chart in %
View a ticker or compare two or three
VS
CLBCX vs. FKIQX commentary
Jul 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Hold and FKIQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 288B vs. FKIQX (79.7B). FKIQX pays higher dividends than CLBCX: FKIQX (5.16) vs CLBCX (1.07). CLBCX was incepted earlier than FKIQX: CLBCX (24 years) vs FKIQX (8 years). CLBCX (1.35) is less costly to investors than FKIQX (0.71). FKIQX is a more actively managed with annual turnover of: 62.14 vs. CLBCX (50.00). CLBCX has a lower initial minimum investment than FKIQX: CLBCX (250) vs FKIQX (1000). CLBCX annual gain was more profitable for investors over the last year : 12.33 vs. FKIQX (11.06). FKIQX (30.84) and CLBCX (30.82) have equivalent 5 years return.
CLBCXFKIQXCLBCX / FKIQX
Total Expense Ratio1.350.71190%
Annual Report Gross Expense Ratio1.350.71190%
Fund Existence24 years8 years-
Gain YTD8.8515.589158%
Front LoadN/A4%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets288B79.7B361%
Annual Yield % from dividends1.075.1621%
Returns for 1 year12.3311.06111%
Returns for 3 years38.9832.25121%
Returns for 5 years30.8230.84100%
Returns for 10 years82.27N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAGHX29.890.83
+2.86%
Virtus KAR Health Sciences A
CCCNX7.800.06
+0.78%
Center Coast Brookfield Midstream Foc I
MCIMX27.000.13
+0.48%
Victory Integrity Mid-Cap Value C
CVERX18.660.01
+0.05%
Columbia Select Mid Cap Value Instl 2
FCGSX33.00-0.39
-1.17%
Fidelity Series Growth Company